Cited by 2,833Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Open access

Cohn, Jay N., Johnson, Gary, Ziesche, Susan, Cobb, Frederick, Francis, Gary, Tristani, Felix, Smith, Raphael, Dunkman, W. Bruce, Loeb, Henry, Wong, Maylene, Bhat, Geetha, Goldman, Steven, Fletcher, Ross D., Doherty, James, Hughes, C. Vincent, Carson, Peter, Cintron, Guillermo, Shabetai, Ralph, Haakenson, Clair·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250502

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared the effects of hydralazine and isosorbide dinitrate with those of enalapril in 804 men receiving digoxin and diuretic therapy for heart failure. The patients were randomly assigned in a double-blind manner to receive 20 mg of enalapril daily or 300 mg of hydralazine plus 160 mg of isosorbide dinitrate daily. The latter regimen was identical to that used with a similar patient population in the effective-treatment arm of our previous Vasodilator-Heart Failure Trial. RESULTS: Mortality after two years was significantly lower in the enalapril arm (18 percent) than in the hydralazine-isosorbide dinitrate arm (25 percent) (P = 0.016; reduction in mortality, 28.0 percent), and overall mortality tended to be lower (P = 0.08). The lower mortality in the enalapril arm was attributable to a reduction in the incidence of sudden death, and this beneficial effect was more prominent in patients with less severe symptoms (New York Heart Association class I or II). In contrast, body oxygen consumption at peak exercise was increased only by hydralazine-isosorbide dinitrate treatment (P less than 0.05), and left ventricular ejection fraction, which increased with both regimens during the 2 years after randomization, increased more (P less than 0.05) during the first 13 weeks in the hydralazine-isosorbide dinitrate group. CONCLUSIONS: The similar two-year mortality in the hydralazine-isosorbide dinitrate arms in our previous Vasodilator-Heart Failure Trial (26 percent) and in the present trial (25 percent), as compared with that in the placebo arm in the previous trial, (34 percent) and the further survival benefit with enalapril in the present trial (18 percent) strengthen the conclusion that vasodilator therapy should be included in the standard treatment for heart failure. The different effects of the two regimens (enalapril and hydralazine-isosorbide dinitrate) on mortality and physiologic end points suggest that the profile of effects might be enhanced if the regimens were used in combination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250502

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Self-citation
A placebo-controlled trial of captopril in refractory chronic congestive heart failure
Captopril Multicenter Research Group (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80316-7 · Cited by 588
Vasodilator Therapy of Cardiac Failure
Cohn, J. N., & Franciosa, J. A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707072970105 · Cited by 483
Self-citation
The role of vasodilator therapy in heart failure
Chatterjee, K., & Parmley, W. W. (1977) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(77)90006-8 · Cited by 315
Vasodilator Therapy for Heart Failure
Cohn, J. N. (1973) · Circulation · doi:10.1161/01.cir.48.1.5 · Cited by 293
Self-citation
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Leier, C. V., Huss, P., Magorien, R. D., & Unverferth, D. V. (1983) · Circulation · doi:10.1161/01.cir.67.4.817 · Cited by 289

Show all 19 references

Research works printed but not linked: 1

Cohn, 1987, Circulation, 76, IV–443

Sorted by citations

Items 201–300 of 1,000

Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure
Baruch, L., Anand, I. S., Cohen, I. S., Ziesche, S., Judd, D., & Cohn, J. N. (1999) · Circulation · doi:10.1161/01.cir.99.20.2658 · Cited by 196
Self-citation
Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction
Aronow, W. S., & Kronzon, I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90520-m · Cited by 196
Diuretics for heart failure
Faris, R. F., Flather, M. D., Purcell, H., Poole-Wilson, P. A., & Coats, A. J. S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003838.pub4 · Cited by 194
Retracted
Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure
Dickstein, K., Chang, P., Willenheimer, R. B., Haunsø, S., Remes, J., Hall, C., & KJEKSHUS, J. K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80020-h · Cited by 193
Health benefit of fucosterol from marine algae: a review
Abdul, Q. A., Choi, R. J., Jung, H. A., & Choi, J. S. (2015) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7489 · Cited by 192
Clinical Depression is Common and Significantly Associated with Reduced Survival in Patients with Non-Ischaemic Heart Failure
Faris, R. F., Purcell, H., Henein, M. Y., & Coats, A. J. S. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00101-0 · Cited by 192
Management of Heart Failure
Baker, D. W. (1994) · JAMA · doi:10.1001/jama.1994.03520190074038 · Cited by 194
Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study
Morisco, C., Trimarco, B., & Condorelli, M. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00226854 · Cited by 191
Summary of Recommendations
Priori, S. G. (2002) · EP Europace · doi:10.1053/eupc.2001.0214 · Cited by 192
Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management
Pappachan, J. M., Varughese, G. I., Sriraman, R., & Arunagirinathan, G. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i5.177 · Cited by 196
Regulation, Chamber Localization, and Subtype Distribution of Angiotensin II Receptors in Human Hearts
Regitz‐Zagrosek, V., Friedel, N., Heymann, A., Bauer, P., Neuß, M., Rolfs, A., Steffen, C., Hildebrandt, A. G., Hetzer, R., & Fleck, E. (1995) · Circulation · doi:10.1161/01.cir.91.5.1461 · Cited by 190
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
Poole-Wilson, P. A. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0839 · Cited by 188
Possible involvement of the adipose tissue renin‐angiotensin system in the pathophysiology of obesity and obesity‐related disorders
Goossens, G. H., Blaak, E. E., & van Baak, M. A. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00091.x · Cited by 188
Hyperpolarization-Activated Inward Current in Ventricular Myocytes From Normal and Failing Human Hearts
Hoppe, U. C., Jansen, E., Südkamp, M., & Beuckelmann, D. J. (1998) · Circulation · doi:10.1161/01.cir.97.1.55 · Cited by 187
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia, and hypomagnesemia
Leier, C. V., Cas, L. D., & Metra, M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90633-5 · Cited by 190
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate
Bersin, R. M., Wolfe, C. L. P., Kwasman, M. A., Lau, D., Klinski, C. S., Tanaka, K., Khorrami, P., Henderson, G. N., Marco, T. D., & Chatterjee, K. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90665-3 · Cited by 186
Heart Failure in the 21st Century: A Cardiogeriatric Syndrome
Rich, M. W. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.2.m88 · Cited by 186
Mechanical Unloading in Heart Failure
Uriel, N. Y., SAYER, G. T., Annamalai, S., Kapur, N. K., & Burkhoff, D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.038 · Cited by 191
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure
Cleland, J. G. F., Erhardt, L., Murray, G. D., Hall, A. S., & Ball, S. (1997) · European Heart Journal · doi:10.1093/eurheartj/18.1.41 · Cited by 186
Comparison between New York Heart Association Classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy
van den Broek, S. A. J., van Veldhuisen, D. J., de Graeff, P. A., Landsman, M. L. J., Hillege, H. L., & Lie, K. I. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90619-a · Cited by 185
Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: Results of a meta-analysis
Packer, M., Antonopoulos, G. V., Berlin, J. A., Chittams, J. L., Konstam, M. A., & Udelson, J. E. (2001) · American Heart Journal · doi:10.1067/mhj.2001.115584 · Cited by 184
Sex Differences in Heart Failure
Lala, A., Tayal, U., HAMO, C. E., Youmans, Q. R., Al‐Khatib, S. M., Bozkurt, B., Davis, M. B., Januzzi, J. L., Mentz, R. J., Sauer, A. J., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.10.006 · Cited by 189
G Protein-Coupled Receptors: A Century of Research and Discovery
Liu, S., Anderson, P. J., Rajagopal, S., Lefkowitz, R. J., & Rockman, H. A. (2024) · Circulation Research · doi:10.1161/circresaha.124.323067 · Cited by 196
Nonpharmacologic Therapy Improves Functional and Emotional Status in Congestive Heart Failure
Kostis, J. B., Rosen, R. C., Cosgrove, N. M., Shindler, D. M., & Wilson, A. C. (1994) · CHEST Journal · doi:10.1378/chest.106.4.996 · Cited by 183
Diastolic heart failure in anaesthesia and critical care
Pirracchio, R., Cholley, B., Hert, S. G. D., Solal, A. C., & Mebazaa, A. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem098 · Cited by 183
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies* on Coronary Prevention
Wood, D., Backer, G. D., Færgeman, O., Graham, I. M., Mancia, G., & Pyörälà, K. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816100-00003 · Cited by 181
Pacing-induced heart failure causes a reduction of delayed rectifier potassium currents along with decreases in calcium and transient outward currents in rabbit ventricle
Tsuji, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00180-2 · Cited by 179
Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey
Morgan, S., Smith, H. E., Simpson, I. A., Liddiard, G. S., Raphael, H., Pickering, R. M., & Mant, D. (1999) · BMJ · doi:10.1136/bmj.318.7180.368 · Cited by 181
Improvement in exercise capacity of candidates awaiting heart transplantation
Stevenson, L. W., Steimle, A. E., Fonarow, G. C., Kermani, M. S., Kermani, D., Hamilton, M. A., Moriguchi, J. D., Walden, J. A., Tillisch, J. H., Drinkwater, D. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00357-v · Cited by 179
Gender Differences in Patients with Heart Failure
Strömberg, A., & Mårtensson, J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00002-1 · Cited by 184
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial
Fonarow, G. C., Chelimsky-Fallick, C., Stevenson, L. W., Luu, M., Hamilton, M. A., Moriguchi, J. D., Tillisch, J. H., Walden, J. A., & Albanese, E. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90529-v · Cited by 177
Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005
Curtis, L. H., Greiner, M. A., Hammill, B. G., Kramer, J. M., Whellan, D. J., Schulman, K. A., & Hernandez, A. F. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2481 · Cited by 180
Diabetes mellitus and congestive heart failure
SOLANG, L. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1472 · Cited by 177
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden)
Savarese, G., Bodegård, J., Norhammar, A., Sartipy, P., Thuresson, M., Cowie, M., Fonarow, G. C., Vaduganathan, M., & Coats, A. J. S. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2271 · Cited by 177
A DNA Variant at the Angiotensin-Converting Enzyme Gene Locus Associates With Coronary Artery Disease in the Caerphilly Heart Study
Mattu, R. K., Needham, E. W., Galton, D. J., Frangos, E., Clark, A., & Caulfield, M. J. (1995) · Circulation · doi:10.1161/01.cir.91.2.270 · Cited by 175
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction
Exner, D. V., Dries, D. L., Waclawiw, M. A., Shelton, B., & Domanski, M. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00675-5 · Cited by 172
Biomass-derived chemical substitutes for bisphenol A: recent advancements in catalytic synthesis
Liguori, F., Moreno‐Marrodán, C., & Barbaro, P. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00179a · Cited by 176
Biventricular pacing in patients with congestive heart failure: two prospective randomized trials
Saxon, L. A., BOEHMER, J. P., Hummel, J. D., Kacet, S., Marco, T. D., Naccarelli, G. V., & Daoud, E. G. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)01012-1 · Cited by 171
Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management
Kearney, M. T., Cotton, J. M., Richardson, P. J., & Shah, A. M. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.903.4 · Cited by 173
Understanding the Basics of Cardiopulmonary Exercise Testing
Milani, R. V., Lavie, C. J., Mehra, M. R., & Ventura, H. O. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.12.1603 · Cited by 174
New Therapeutic Options in Congestive Heart Failure: Part I
McMurray, J. J. V., & Pfeffer, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000014763.63528.9d · Cited by 168
Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress
Daiber, A., & Münzel, T. F. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6376 · Cited by 173
Medical Treatment of Aortic Stenosis
Marquis‐Gravel, G., Redfors, B., Leon, M. B., & Généreux, P. (2016) · Circulation · doi:10.1161/circulationaha.116.023997 · Cited by 181
Leitlinien zur Therapie der chronischen Herzinsuffizienz
Hoppe, U. C., Böhm, M., Dietz, R., Hanrath, P., Kroemer, H. K., Osterspey, A., SCHMALTZ, A. A., & Erdmann, E. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0268-4 · Cited by 181
Double-Blind Placebo-Controlled Study of Ibopamine and Diagoxin in Patients With Mild to Moderate Heart Failure: Results of the Dutch of the Ibopamine Multicenter Trial (DIMT)
van Veldhuisen, D. J., Veld, A. J. M. I., Dunselman, P. H. J. M., Lok, D. J. A., Dohmen, H. J. M., Poortermans, J. C., Withagen, A. J. A. M., Pasteuning, W. H., Brouwer, J., & Lie, K. I. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90579-p · Cited by 166
Pharmacotherapy for Heart Failure in Patients with Renal Insufficiency
Shlipak, M. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00013 · Cited by 167
Sudden death in idiopathic dilated cardiomyopathy
Tamburro, P., & Wilber, D. J. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90989-9 · Cited by 162
Evaluating Quality of Care for Patients With Heart Failure
Krumholz, H. M., Baker, D. W., Ashton, C. M., Dunbar, S. B., Friesinger, G. C., Havranek, E. P., Hlatky, M. A., Konstam, M. A., Ordin, D. L., Piña, I. L., et al. (2000) · Circulation · doi:10.1161/01.cir.101.12.e122 · Cited by 160
Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
Kittleson, M. M., Hurwitz, S., Shah, M., Nohria, A., Lewis, E. F., Givertz, M. M., Fang, J. C.-T., Jarcho, J. A., Mudge, G. H., & Stevenson, L. W. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00417-0 · Cited by 160
The health care costs of heart failure in Sweden
Rydén‐Bergsten, T., & Andersson, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00520.x · Cited by 161
Nitroso–Redox Balance in the Cardiovascular System
Hare, J. M. (2004) · New England Journal of Medicine · doi:10.1056/nejme048269 · Cited by 162
Perioperative Management of Chronic Heart Failure
Groban, L., & Butterworth, J. F. I. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000226099.60493.d9 · Cited by 159
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
Yee, K.-M., Pringle, S. D., & Struthers, A. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01243-8 · Cited by 160
Demographics and concomitant disorders in heart failure
Krum, H., & Gilbert, R. E. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13869-x · Cited by 161
Heart failure in the 1990s: Evolutions of a major public health problem in cardiovascular medicine
Garg, R., Packer, M., Pitt, B., & Yusuf, S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90454-9 · Cited by 159
Evidence for altered interleukin (IL)‐18 pathway in human heart failure
Mallat, Z., Heymes, C., Corbaz, A., Logeart, D., Alouani, S., Solal, A. C., Seidler, T., Hasenfuss, G. P., Chvatchko, Y., Shah, A. M., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2426fje · Cited by 160
Heart failure
Krum, H., & Abraham, W. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60236-1 · Cited by 166
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction
Rogers, W. J., Johnstone, D. E., Yusuf, S., Weiner, D. H., Gallagher, P. N., Bittner, V., Ahn, S. A., SCHRON, E. B., Shumaker, S. A., & Sheffield, L. T. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90426-x · Cited by 158
Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD)
Kostis, J. B., Shelton, B. J., Gosselin, G., Goulet, C., Hood, W. B., Kohn, R. M., Kubo, S. H., SCHRON, E. B., Weiss, M. B., Willis, P. W., et al. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90365-8 · Cited by 158
Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure.
Osterziel, K. J., Hänlein, D., Willenbrock, R., Eichhorn, C., Luft, F. C., & Dietz, R. (1995) · Heart · doi:10.1136/hrt.73.6.517 · Cited by 156
The Incidence and Prevalence of Congestive Heart Failure in Rochester, Minnesota
Rodeheffer, R. J., Jacobsen, S. J., Gersh, B. J., Kottke, T. E., McCann, H. A., Bailey, K. R., & Ballard, D. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60063-9 · Cited by 157
Prevalence, aetiology and management of heart failure in general practice.
Mair, F. S., Crowley, T. S., & Bundred, P. E. (1996) · PubMed Central · Cited by 156
Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in Rats
Bruckschlegel, G., Holmer, S. R., Jandeleit-Dahm, K. A. M., Grimm, D. G., Muders, F., Kromer, E. P., Riegger, G. A. J., & Schunkert, H. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.250 · Cited by 155
The Natriuretic Peptides in Heart Failure: Diagnostic and Therapeutic Potentials
Chen, H. H., & Burnett, J. C. J. (1999) · Proceedings of the Association of American Physicians · doi:10.1111/paa.1999.111.5.406 · Cited by 156
Will tomorrow's medicines work for everyone?
Tate, S. K., & Goldstein, D. B. (2004) · Nature Genetics · doi:10.1038/ng1437 · Cited by 154
Use of echocardiography in the management of congestive heart failure in the community
Senni, M., Rodeheffer, R. J., Tribouilloy, C. M., Evans, J. M., Jacobsen, S. J., Bailey, K. R., & Redfield, M. M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00523-3 · Cited by 153
Cost-effectiveness Analysis in Clinical Practice
Rich, M. W., & Nease, R. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.15.1690 · Cited by 154
Diuretics for heart failure
Faris, R. F., Flather, M. D., Purcell, H., Poole-Wilson, P. A., & Coats, A. J. S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003838.pub3 · Cited by 165
Retracted
The endothelin system and its potential as a therapeutic target in cardiovascular disease
Gray, G. A., & Webb, D. J. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00101-5 · Cited by 154
Management of Heart Failure
Dracup, K. (1994) · JAMA · doi:10.1001/jama.1994.03520180066037 · Cited by 155
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G. L., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C. S., et al. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.06.001 · Cited by 151
Tailored Therapy to Hemodynamic Goals for Advanced Heart Failure
Stevenson, L. W. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00015-x · Cited by 153
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
Backer, G. D., Ambrosio, G., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · PubMed · doi:10.1097/01.hjr.0000087913.96265.e2 · Cited by 153
Race-based therapeutics
Bloche, M. G. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048271 · Cited by 150
Failure of Women’s Hearts
Petrie, M. C., Dawson, N., Murdoch, D. R., Davie, A. P., & McMurray, J. J. V. (1999) · Circulation · doi:10.1161/01.cir.99.17.2334 · Cited by 150
Prediction of Response to Cardiac Resynchronization Therapy: The Selection of Candidates for CRT (SCART) Study
Achilli, A., Peraldo, C., Sassara, M., Orazi, S., Bianchi, S., Laurenzi, F., DONATI, R., Perego, G. B., Spampinato, A., Valsecchi, S., et al. (2006) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2006.00486.x · Cited by 150
Effects of Repeated Sauna Treatment on Ventricular Arrhythmias in Patients With Chronic Heart Failure
Kihara, T., Biro, S., Ikeda, Y., Fukudome, T., Shinsato, T., Masuda, A., Miyata, M., Hamasaki, S., Otsuji, Y., Minagoe, S., et al. (2004) · Circulation Journal · doi:10.1253/circj.68.1146 · Cited by 151
Cardiac transplantation: recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association.
OʼConnell, J. B., Bourge, R. C., Costanzo-Nordin, M. R., Driscoll, D. J. O., Morgan, J. P., Rose, E. A., & Uretsky, B. F. (1992) · Circulation · doi:10.1161/01.cir.86.3.1061 · Cited by 148
ACE Inhibitors — A Cornerstone of the Treatment of Heart Failure
Braunwald, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250508 · Cited by 148
Repolarization Abnormalities, Arrhythmia and Sudden Death in Canine Tachycardia-Induced Cardiomyopathy
Pak, P. H., Nuss, H. B., Tunin, R. S., Kääb, S., Tomaselli, G. F., Marbán, E., & Kass, D. A. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00193-9 · Cited by 148
Comprehensive multidisciplinary programs for the management of patients with congestive heart failure
Philbin, E. F. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.00291.x · Cited by 146
Effect of a Strategy of Comprehensive Vasodilation vs Usual Care on Mortality and Heart Failure Rehospitalization Among Patients With Acute Heart Failure
Kozhuharov, N., Goudev, A., Flores, D., Maeder, M. T., Walter, J. E., Shrestha, S., Gualandro, D. M., de Oliveira, M. T., Sabti, Z., Müller, B., et al. (2019) · JAMA · doi:10.1001/jama.2019.18598 · Cited by 148
Relation of daily activity levels in patients with chronic heart failure to long-term prognosis
Walsh, J. T., Charlesworth, A., Andrews, R. V., Hawkins, M., & Cowley, A. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00141-0 · Cited by 145
Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure
Cohn, J. N., Tognoni, G., Glazer, R. D., Spormann, D., & Hester, A. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)90038-6 · Cited by 146
Self-citation
Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure
Dibner‐Dunlap, M. E., Smith, M. L., Kinugawa, T., & Thames, M. D. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00484-x · Cited by 143
Insights into the contemporary epidemiology and outpatient management of congestive heart failure
McAlister, F. A., Teo, K. K., Taher, M., Montague, T. J., Humen, D. P., Cheung, L. K., Kiaii, M., Yim, R., & Armstrong, P. W. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70251-6 · Cited by 144
Successes and failures of current treatment of heart failure
Cleland, J. G., Swedberg, K., & Poole-Wilson, P. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90015-0 · Cited by 141
Effects of Dihydrocodeine on Chemosensitivity and Exercise Tolerance in Patients With Chronic Heart Failure
Chua, T. P., Harrington, D., Ponikowski, P. P., Webb-Peploe, K., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00446-9 · Cited by 141
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony
Fruhwald, F. M., Fahrleitner‐Pammer, A., Berger, R., Leyva, F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., Daubert, J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl505 · Cited by 142
Congestive Heart Failure After Surgical Correction of Mitral Regurgitation
Enriquez-Sarano, M. L., Schaff, H. V., Orszulak, T. A., Bailey, K. R., Tajik, A. J., & Frye, R. L. (1995) · Circulation · doi:10.1161/01.cir.92.9.2496 · Cited by 140
The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice
Zimetbaum, P. J., & Josephson, M. E. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00020 · Cited by 139
How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease
Packer, M. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90081-m · Cited by 141
Controlled Clinical Evaluation of Enalapril in Dogs With Heart Failure: Results of the Cooperative Veterinary Enalapril Study Group The COVE Study Group
Woodfield, J. A. (1995) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1995.tb01075.x · Cited by 139
Statins and Blockers of the Renin-Angiotensin System
Faggiotto, A., & Paoletti, R. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.987 · Cited by 139
MYOBLAST CELL GRAFTING INTO HEART MUSCLE: Cellular Biology and Potential Applications
Kessler, P. D., & Byrne, B. J. (1999) · Annual Review of Physiology · doi:10.1146/annurev.physiol.61.1.219 · Cited by 138
Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure
Gogia, H., Mehra, A., Parikh, S., Raman, M., Ajit-Uppal, J., Johnson, J. V., & Elkayam, U. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00368-1 · Cited by 137
The STICH Trial (Surgical Treatment for Ischemic Heart Failure)
Carson, P. E., WERTHEIMER, J. H., Miller, A. B., O’Connor, C. M., Piña, I. L., Selzman, C. H., Sueta, C. A., She, L., Greene, D., Lee, K. L., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.04.012 · Cited by 141
Self-citation
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.
(1998) · Europe PMC (PubMed Central) · Cited by 143
Diastolic dysfunction as a cause of heart failure
Litwin, S. E., & Grossman, W. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90463-b · Cited by 134
Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype
Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Cabrini, G., Bonizzato, A., Graziani, M., Anker, S. D., Coats, A. J. S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01237-2 · Cited by 137

Authors: Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., Bhat, G., Goldman, S., Fletcher, R. D., Doherty, J., Hughes, C. V., Carson, P., Cintron, G., Shabetai, R., & Haakenson, C.
Affiliations: University of Minnesota (US)
ORCID: Cohn, Jay N.
Johnson, Gary
Bhat, Geetha
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 303-310
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250502
OpenAlex: W2046383587
Cited by: 2,833
References: 19
Citations by year: 2026: 14 · 2025: 15 · 2024: 26 · 2023: 21 · 2022: 31 · 2021: 27 · 2020: 46 · 2019: 39 · 2018: 51 · 2017: 56 · 2016: 69 · 2015: 59 · 2014: 54 · 2013: 61 · 2012: 56
FWCI: 124.25
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, hydralazine, isosorbide dinitrate, chronic congestive heart failure, vasodilator therapy, mortality, sudden death, exercise oxygen consumption, left ventricular ejection fraction, ACE inhibitors, combination therapy, digoxin, diuretics, NYHA functional class
MeSH terms: Adolescent, Adult, Aged, Chronic Disease, Death, Sudden, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Enalapril, Physical Exertion, Heart Failure, Hospitalization, Humans, Hydralazine, Isosorbide Dinitrate, Male, Middle Aged, Norepinephrine, Oxygen Consumption, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks